Johnson & Johnson says it aims to have more than half a billion coronavirus vaccines ready early next year.
The pharmaceutical giant will have 600 million to 800 million
vaccines available in early 2021, when it expects the US government to
approve the drug it plans to start testing in humans this September,
chief financial officer Joe Wolk said Tuesday.
“The timeline still is pretty certain,” Wolk told Yahoo Finance
in an interview. “We’re manufacturing at risk to ensure that should the
clinical development and the trials be successful, we are in a position
to kind of flip the switch and ready to go to create great access
across the globe.”
The company aims to ramp up production to 1 billion doses annually by
the end of next year, Wolk said in the interview. J&J and the
federal Biomedical Advanced Research and Development Authority announced
a $1 billion investment last month to help achieve that goal.
J&J plans to set up a new manufacturing facility in the US to
supplement the company’s plant in the Netherlands that can produce up to
300 million doses. The stateside factory will be up and running later
this year or early next year, Wolk told Yahoo.
https://nypost.com/2020/04/15/johnson-johnson-eyes-600-million-coronavirus-vaccines-by-early-2021/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.